06
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection
Addressing bacterial resistance – an international and multidisciplinary group of researchers including MedLab Fellow Noé Brasier, MD, and Prof. Jörg Goldhahn, MD, at the Institute of Translational Medicine at ETH Zurich, describes a novel model to determine the antimicrobial concentrations at the site of infection by implementing wearable biofluid analysis.